Cystic fibrosis lung disease: Current perspectives
- Author:
Jin A JUNG
1
Author Information
- Publication Type:Review
- Keywords: Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Chloride-bicarbonate transport; Epithelial sodium channel
- MeSH: Airway Obstruction; Chloride Channels; Cystic Fibrosis Transmembrane Conductance Regulator; Cystic Fibrosis; Epithelial Cells; Epithelial Sodium Channels; Half-Life; Inflammation; Intestines; Lung Diseases; Lung; Membranes; Models, Animal; Mortality; Pancreas
- From:Allergy, Asthma & Respiratory Disease 2020;8(1):3-8
- CountryRepublic of Korea
- Language:Korean
- Abstract: Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). These mutations alter the synthesis, processing, function, or half-life of CFTR, the main chloride channel expressed in the apical membrane of epithelial cells in the airway, intestine, pancreas, and reproductive tract. Lung disease is the most critical manifestation of CF. It is characterized by airway obstruction, infection, and inflammation that lead to fatal tissue destruction, which causes most CF morbidity and mortality. This article reviews the pathophysiology of CF, recent animal models, and current treatment of CF.
